The Scottish Dementia Research Consortium Conference 2019

Each year the Scottish Dementia Research Consortium (SDRC) holds a very inclusive conference for their members as well as for the members of the public who are keen on learning about dementia research in Scotland. This year, the annual conference was held on the 15th of April at the Radisson Blu in Glasgow, and among the speakers there was Prof Andrew Tobin, who gave an insightful talk about the research done by his group on the M1 muscarinic acetylcholine receptor as a drug target for Alzheimer’s disease, the most common cause of dementia. Also, PhD students Miriam Scarpa and Sarah Hesse attended the conference, and gave a short talk about their projects – Miriam talked about the importance of promoting the phosphorylation of the M1 receptor when pharmacologically targeted, and Sarah talked about investigating the potential of targeting the M1 receptor using allosteric modulators in a mouse model of tauopathy (Tg4510).

The conference was very successful, with over 150 attendees, and it was an amazing opportunity to showcase all the world-leading dementia research that is taking place in Glasgow, and the rest of Scotland.

Prof Andrew Tobin

First published: 26 August 2019

<< Archive